STING1 and type 2 diabetes mellitus: Moreover, IRF3 has been found to activate hepatic injury through the STING-IRF3 pathway,32 trigger endothelial inflammation induced by free fatty acids,33 and participate in β-cell lipotoxicity in type 2 diabetes.34